KRXCX Fees and Costs — Kinetics Medical Fund, Advisor Class C
Data updated: 2023-03-16
The net expense ratio is 2.14%: a 1.25% management fee, a 1.00% 12b-1 fee plus 0.67% other expenses, less a 0.78% fee waiver. This share class carries a deferred sales charge of up to 1.00% and a redemption fee of 2.00%. Portfolio turnover was 1%.
KRXCX Fees and Expenses
Annual operating expenses and sales charges of KRXCX. Prospectus, as of April 30, 2022.
| Annual operating expenses | |
|---|---|
| Management fee | 1.25% |
| 12b-1 fee | 1.00% |
| Other expenses | 0.67% |
| Gross expense ratio | 2.92% |
| Fee waiver | −0.78% |
| Net expense ratio | 2.14% |
| Sales charges | |
|---|---|
| Max front load | 0.00% |
| Max deferred load | 1.00% |
| Redemption fee | 2.00% |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | No |
KRXCX Costs Over Time
On $10,000 invested in KRXCX, assuming 5% a year before costs, total costs come to $1,308 over 5 years, cutting the return by 2.25% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Sales charges | $103 | $0 | $0 |
| Fund expenses (net expense ratio 2.14%) | $225 | $693 | $1,187 |
| Lost growth on money paid in costs | $0 | $35 | $121 |
| Total costs | $327 | $727 | $1,308 |
| Value after costs | $10,173 | $10,849 | $11,454 |
| Impact on return, per year | 3.27% | 2.25% | 2.25% |
KRXCX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending December 31, 2022.
- Explicit cost rate (commissions ÷ average net assets): —
- Total broker commissions: —
- Bought from dealers (principal trades, not a cost): —
- Portfolio turnover (prospectus): 1%
- Securities lending: none during the year
KRXCX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| BNY MELLON CAPITAL MARKETS LLC | $240 | 53.33% |
| WEEDEN & CO.L.P. | $160 | 35.56% |
| VIRTU ITG LLC | $50 | 11.11% |
Kinetics Medical Fund Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| MEDRX | No Load Class | 1.39% | — |
| KRXAX | Advisor Class A | 1.64% | 5.75% |
| KRXCX | Advisor Class C | 2.14% | none |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.